1. Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough
- Author
-
Krishna M. Sundar, Julie Barkmeier-Kraemer, Miranda L Wright, and Jennifer S. Herrick
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Long term treatment ,business.industry ,Treatment adherence ,Treatment outcome ,Cough duration ,Speech therapy ,Chronic cough ,Telephone interview ,Refractory ,Internal medicine ,Medicine ,medicine.symptom ,business - Abstract
Current literature reveals that up to 88% of individuals undergoing behavioral speech therapy (BST) for chronic refractory cough (CRC) demonstrate benefit at 4–8 weeks post-treatment. However, investigations of BST are confounded by overlapping use of neuromodulators, missing follow-up data, and an absence of long-term outcomes. This study investigated treatment outcomes beyond 6 months in individuals diagnosed with CRC, and whose treatment outcomes were clinically undocumented. Participants with CRC 6 months or greater beyond treatment completion were recruited. Participants completed a post-treatment Leicester Cough Questionnaire (LCQ) and a telephone interview. Demographic data, cough characteristics, treatment adherence, BST outcomes, and pre- and post-treatment LCQ scores were evaluated. 80 individuals met inclusion criteria and 29 consented to participate. Of these, 27 were recommended BST. The majority were female (19/27) with average age of 58 years (SD = 12). Mean cough duration was 60 months (SD = 98) and mean post-BST duration was 20 months (SD = 9). A significant increase in pre- to post-treatment LCQ scores occurred [4.4 (SD = 4.2)] (p
- Published
- 2021